Vascular Endothelial Growth Factor-B (VEGF-B) Blockade With the Monoclonal Antibody CSL346 in Subjects With Diabetic Kidney Disease

Middlemore Hospital, Auckland

Hunter Diabetes Centre - The AIM Centre, Merewether

Sunshine Hospital, St Albans

The Royal Melbourne Hospital, Parkville

St Vincent's Hospital, Fitzroy

The Austin Hospital, Heidelberg

Lyell McEwin Hospital, Elizabeth Vale

Endocrine Associates - Wellington, Wellington

Christchurch Hospital, Christchurch

Lipid and Diabetes Research Group, Christchurch

Center for Thyroid & Parathyroid Disorders, Staten Island

Physicians East, P.A. - Endocrinology, Greenville

West Orange Endocrinology, Ocoee

Vanderbilt University School of Medicine, Nashville

3760044 - Tel Aviv Sourasky Medical Center, Tel Aviv

University of Missouri Health System, Columbia

Omega Clinical Research, Metairie

3760045 - Kaplan Medical Center, Rehovot

Juno Research, L.L.C., Houston

The Endocrine Center, Houston

Renal Associates, P.A. - San Antonio, San Antonio

Primary Care Providers of Texas, San Antonio

Diabetes and Metabolism Specialists (DMS) - San Antonio, San Antonio

Palm Medical Group, LLC - Las Vegas, Las Vegas

Renal Medical Associate/NARI, Lynwood

Torrance Clinical Research (TCR) - Lomita, Lomita

Amicis Research Center, Northridge

California Medical Research Associates, Inc, Northridge

California Kidney Specialists (CKS) - Citrus Office, Covina

Riverside Nephrology Group, Riverside

Valley Research - Fresno, Fresno

East-West Medical Research Institute, Honolulu

Tufts Medical Center, Boston

Renal and Transplant Associates, Springfield

1240130 - University Health Network, Toronto

Fundación de Investigación, San Juan

University of Puerto Rico - Puerto Rico Clinical and TRC, San Juan